GSK increases stake in Indian Pharmaceuticals subsidiary to 75 per cent after Open Offer

GlaxoSmithKline plc announced today that, following the voluntary Open Offer undertaken by its subsidiary, GlaxoSmithKline Pte Ltd, it has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India.

Source: GSK news - March 10, 2014 Category: Pharmaceuticals Source Type: news